/>

Patient Name : Mrs.GAGANDEEP KAUR WO AVTAR SINGH Pateint ID : 10148210

Age/Gender : 27 Y/Female Registration ON : 24/May/2023 01:11PM
LabNo : 052305240050 Sample Collected ON : 24/May/2023 01:30PM
Referred By : Dr. SNIGDHA KHURANA Sample Received ON : 24/May/2023 01:30PM
Collected At :KHURANA IVF CENTRE Report Generated ON : 24/May/2023 02:50PM

Test Name Value Unit Reference Range

BIOCHEMISTRY
Liver Function Test
SGPT(ALT) 190 U/L 0 - 45
IFCC Kinetic
SGOT(AST) 196 U/L 0 - 35
IFCC Kinetic

Alkaline Phosphatase (ALP) 340 U/L 30 - 120

Biuret Method
Bilirubin, Total 0.8 mg/dL 0.3-1.2
Diazo,End Point

Bilirubin,Direct 0.3 mg/dl < 0.3

Diazo,End Point
Bilirubin,Indirect 0.5 mg/dL 0.1-1.0
Calculated
TOTAL PROTIENS 6.9 g/dL
Biuret Method, End Point
Method: Biuret Method, End Point
Albumin 3.7 g/dL 3.5-5.2
Dye Method, End Point
Globulin 3.2 g/dL 2.0-3.5
Calculated

A:G Ratio 1.2 % 1.0-1.8

Calculated

Comment:
Bilirubin is a yellowish pigment found in bile and is a breakdown product of normal heme catabolism. Elevated levels results from increased bilirubin production
(eg hemolysis and ineffective erythropoiesis); decreased bilirubin excretion (eg; obstruction and hepatitis); and abnormal bilirubin metabolism (eg; hereditary
and neonatal jaundice). Conjugated (direct) bilirubin is elevated more than unconjugated (indirect) bilirubin in viral hepatitis; drug reactions, alcoholic liver
disease or blockage of the bile ducts like in Gallstones getting into the bile ducts tumors &Scarring of the bile ducts.. AST levels increase in viral hepatitis,
blockage of the bile duct ,cirrhosis of the liver, liver cancer, kidney failure, hemolytic anemia, pancreatitis, hemochromatosis. ALT is commonly measured as a
part of a diagnostic evaluation of hepatocellular injury, to determine liver health. Elevated ALP levels are seen in Biliary Obstruction, Osteoblastic Bone
Tumors, Osteomalacia, Hepatitis, Hyperparathyriodism, Leukemia, Lymphoma paget`s disease, Rickets, Sarcoidosis etc.

Page 1 of 2
 />

Patient Name : Mrs.GAGANDEEP KAUR WO AVTAR SINGH Pateint ID : 10148210

Age/Gender : 27 Y/Female Registration ON : 24/May/2023 01:11PM
LabNo : 052305240050 Sample Collected ON : 24/May/2023 01:30PM
Referred By : Dr. SNIGDHA KHURANA Sample Received ON : 24/May/2023 01:30PM
Collected At :KHURANA IVF CENTRE Report Generated ON : 24/May/2023 02:50PM

Test Name Value Unit Reference Range

Immunology
BILE ACIDS TOTAL, SERUM
BILE ACIDS TOTAL, SERUM 11.50 µmol/L 0.50-10.00
Note:-

Normal values for serum bile acids and transaminases may occasionally be seen, women with persisting pruritus and normal
bile acids / ALT should have repeat tests every 1-2 weeks.
Following meals, 2-5 fold increase in bile acid levels can be observed.
Results should be interpreted with caution in Ursodeoxycholic acid (UDCA) treated patient as UDCA itself is a bile acid and
may get measured by this assay.
For patients treated with UDCA- LCMS/MS is recommended method for monitoring response to treatment.

Comments:-
Total bile acids are metabolized in the liver and can serve as a marker for normal liver function. Increases in serum bile acids
are seen in patients with Acute Hepatitis, Chronic Hepatitis, Liver Sclerosis, Liver Cancer, and Intrahepatic Cholestasis of
Pregnancy (ICP). ICP can lead to increased risk of fetal distress, preterm delivery and even still birth. The risk of fetal
complications seem to correlate with maternal serum bile acid levels at a critical threshold of 40 μmol/L in fasting and 100
μmol/L in post prandial state.

*** End Of Report ***

Page 2 of 2